Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing

被引:0
|
作者
Qiubing Chen [1 ,2 ]
Xuebin Wang [1 ,2 ]
Yizhou Zhang [1 ,2 ]
Ming Tian [1 ,2 ]
Junyi Duan [1 ,2 ]
Ying Zhang [1 ,3 ]
Hao Yin [1 ,2 ,4 ,5 ]
机构
[1] Departments of Urology and Laboratory Medicine,Frontier Science Center for Immunology and Metabolism, Medical Research Institute,Zhongnan Hospital of Wuhan University,Wuhan University
[2] State Key Laboratory of Virology,Tai Kang Center for Life and Medical Sciences, Tai Kang Medical School,Wuhan University
[3] Department of Rheumatology and Immunology,Zhongnan Hospital of Wuhan University,Wuhan University
[4] Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences
[5] RNA Institute,Wuhan
关键词
D O I
暂无
中图分类号
Q78 [基因工程(遗传工程)]; TB383.1 [];
学科分类号
071007 ; 0836 ; 090102 ;
摘要
Lipid nanoparticles(LNPs) have gained clinical approval as carriers for both siRNA and mRNA. Among the crucial components of LNPs, ionizable lipids play a pivotal role in determining the efficiency of RNA delivery. In this study, we synthesized a series of ionizable lipids, denoted as HTO, with a higher count of hydroxyl groups compared to SM-102. Remarkably, LNPs based on HTO12 lipid demonstrated comparable mRNA delivery efficiency and biosafety to those based on SM-102. However, the former reduced the ratio of ionizable lipid/total lipids to mRNA in LNPs by 2.5 times compared to SM-102. The HTO12 LNP efficiently encapsulated adenine base editor mRNA and sgRNA targeting Pcsk9, leading to substantial gene editing within the liver of mice and effective reduction of the target protein. Our study underscores that ionizable lipids with multiple hydroxyl groups may facilitate an improved lipid-to-mRNA ratio to minimize the dosage of ionizable lipids for in vivo delivery.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 50 条
  • [21] Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
    Lewis, Mae M.
    Soto, Melissa R.
    Maier, Esther Y.
    Wulfe, Steven D.
    Bakheet, Sandy
    Obregon, Hannah
    Ghosh, Debadyuti
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (06)
  • [22] Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid
    Suzuki, Yuta
    Ishihara, Hiroshi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 510 (01) : 350 - 358
  • [23] Optimization of Ionizable Lipid Structure to Modulate ApoE Binding and Enable Stealth Lipid Nanoparticles
    Vinciguerra, Daniele
    Rose, Douglas
    Serizier, Sandy
    Milstead, Andrew
    Gallagher, Nolan
    Syrovatkina, Viktoriya
    Delaney, Ryan
    Li, Prudence
    Bush, Di
    Stanton, Matthew
    Toy, Randall
    MOLECULAR THERAPY, 2024, 32 (04) : 591 - 591
  • [24] Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing
    Sun, Qian
    Zhang, Hongqian
    Ding, Feng
    Gao, Xue
    Zhu, Zongwei
    Yang, Chuanxu
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 652
  • [25] Ionizable Lipid with Supramolecular Chemistry Features for RNA Delivery In Vivo
    Manning, Alanna M.
    Tilstra, Grayson
    Khan, Aniqa B.
    Couture-Senecal, Julien
    Lau, Yan Ming Anson
    Pang, Janice
    Abow, Amina A.
    Robbins, Clinton S.
    Khan, Omar F.
    SMALL, 2023, 19 (41)
  • [26] Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
    Schlich, Michele
    Palomba, Roberto
    Costabile, Gabriella
    Mizrahy, Shoshy
    Pannuzzo, Martina
    Peer, Dan
    Decuzzi, Paolo
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (02)
  • [27] In Vivo CRISPR Base Editing of Angptl3 via Lipid Nanoparticle Delivery
    Khirallah, Jennifer
    Bloomer, Hanan
    Newby, Gregory
    Rhee, Hyunjoon
    Eimbinder, Maximilian
    Huang, Changfeng
    Li, Yamin
    Chen, Zheng-Yi
    Liu, David
    Xu, Qiaobing
    MOLECULAR THERAPY, 2023, 31 (04) : 247 - 248
  • [28] Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome
    Mrksich, Kaitlin
    Padilla, Marshall S.
    Mitchell, Michael J.
    ADVANCED DRUG DELIVERY REVIEWS, 2024, 214
  • [29] In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
    Billingsley, Margaret M.
    Gong, Ningqiang
    Mukalel, Alvin J.
    Thatte, Ajay S.
    El-Mayta, Rakan
    Patel, Savan K.
    Metzloff, Ann E.
    Swingle, Kelsey L.
    Han, Xuexiang
    Xue, Lulu
    Hamilton, Alex G.
    Safford, Hannah C.
    Alameh, Mohamad-Gabriel
    Papp, Tyler E.
    Parhiz, Hamideh
    Weissman, Drew
    Mitchell, Michael J.
    SMALL, 2024, 20 (11)
  • [30] Calculating Apparent pK a Values of Ionizable Lipids in Lipid Nanoparticles
    Hamilton, Nicholas B.
    Arns, Steve
    Shelley, Mee
    Bechis, Irene
    Shelley, John C.
    MOLECULAR PHARMACEUTICS, 2024, 22 (01) : 588 - 593